CLOSED-LOOP ARCHITECTURE FOR DISTRIBUTING AND ADMINISTERING MEDICINES TO PATIENTS

• Main Authors: SHTEIN, Max, MOAYER, Mohsen
• Format: Patent
• Language: English; French; German
• Published: 05.03.2025
• Subjects: CALCULATING; COMPUTER SYSTEMS BASED ON SPECIFIC COMPUTATIONAL MODELS; COMPUTING; COUNTING; DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY; HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATIONTECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING ORPROCESSING OF MEDICAL OR HEALTHCARE DATA; HUMAN NECESSITIES; HYGIENE; INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTEDFOR SPECIFIC APPLICATION FIELDS; MEDICAL OR VETERINARY SCIENCE; PHYSICS

The following relates generally to administering and delivering medications to patients. In some embodiments, an in-home appliance may place an ingestible ingredient (e.g., an active pharmaceutical ingredient (API) of a medication) on a physical substrate to create a distributable/retrievable object, which is distributed to a subject. The subject may then consume at least a portion of the ingestible ingredient, and then return at least a portion of the distributable/retrievable object to the appliance. The appliance, upon receiving the object, can subsequently trigger secondary actions, including logging the consumption of the dose; authorizing the next dose to override security measures which would otherwise block access to additional doses; analyzing the returned object for biometrics or remaining amount of ingestible ingredients, etc. Logged data will populate a software database on the cloud which can integrate with any number of internal and external systems, triggering programmable actions within a closed-loop architecture.